carbon tetrachloride has been researched along with givinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meng, WY; Shi, M; Wang, N; Wang, T; Wang, YG; Wei, J; Xu, L | 1 |
| Fan, SJ; Huang, HM; Huang, J; Li, GM; Liao, LP; Liu, YJ; Luo, C; Pen, JJ; Shi, CC; Yu, L; Zhang, YY; Zhou, XR | 1 |
2 other study(ies) available for carbon tetrachloride and givinostat
| Article | Year |
|---|---|
Givinostat inhibition of hepatic stellate cell proliferation and protein acetylation.
Topics: Acetylation; Animals; Apoptosis; Apoptosis Regulatory Proteins; Carbamates; Carbon Tetrachloride; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line; Cell Movement; Cell Proliferation; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Hepatic Stellate Cells; Histone Deacetylase Inhibitors; Liver Cirrhosis, Experimental; Male; Mice, Inbred BALB C; NF-kappa B; Protein Processing, Post-Translational; Signal Transduction; Superoxide Dismutase; Time Factors | 2015 |
Histone deacetylase inhibitor givinostat alleviates liver fibrosis by regulating hepatic stellate cell activation.
Topics: Animals; Carbamates; Carbon Tetrachloride; Cell Line; Female; Gene Expression Profiling; Gene Expression Regulation; GPI-Linked Proteins; Hepatic Stellate Cells; Histone Deacetylase Inhibitors; Humans; Intercellular Signaling Peptides and Proteins; Liver; Liver Cirrhosis; Mesothelin; Mice; Mice, Inbred C57BL; Rats; Uroplakin III | 2021 |